ProCE Banner Activity

Expanding Therapeutic Choices in Atopic Dermatitis: Emerging Agents in AD: Current Evidence

Slideset

The therapeutic landscape for atopic dermatitis (AD) is expanding rapidly. There are several novel agents available and more on the horizon with proven durable efficacy and favorable safety profiles. Download these slides to learn about new and emerging targeted therapies for managing AD.

Released: July 17, 2023

Share

Provided by

Provided by Partners for Advancing Clinical Education (PACE)

ProCE Banner

Supporters

This activity is supported by educational grants from AbbVie Inc, Galderma, and Lilly.

AbbVie Inc.

Galderma

Lilly